Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingying Yu

Showing results (201-210 of 243) with videos related to

Pageof 25
Sort By:
Frontiers in Immunology|June 17, 2022
Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational TherapyShida Pan, Yingying Yu, Siyu Wang, et al.
Drugs in R&D|September 4, 2024
Pharmacokinetics, Mass Balance, and Biotransformation of [<sup>14</sup>C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy SubjectsShumao Ni, Sheng Ma, Yingying Yu, et al.
Cell Discovery|October 17, 2023
Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosisZhaoxian Cai, Xiaotian Wu, Zijun Song, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2021
Temporarily Epigenetic Repression in Bergmann Glia Regulates the Migration of Granule CellsShaoxuan Chen, Kunkun Zhang, Boxin Zhang, et al.
Frontiers in Immunology|April 23, 2026
Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemiaJianing Wang, Shida Pan, Chuyue Xiong, et al.
Frontiers in Immunology|May 13, 2026
Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemiaJianing Wang, Shida Pan, Chuyue Xiong, et al.
Plant Physiology and Biochemistry : PPB|April 16, 2025
Mechanisms of biocontrol of gray mold in postharvest pear fruits using the termite symbiont Streptomyces griseus H3950Daojing Yong, Yingying Yu, Shuai Zhao, et al.
Annals of Palliative Medicine|May 12, 2021
Clinical efficacy evaluation and prevention of adverse reactions in a randomized trial of a combination of three drugs in the treatment of cancerous pudendal neuralgiaJunjie Hou, Yifan Lin, Yanqiu Fang, et al.
Nature Communications|February 3, 2025
NAPTUNE: nucleic acids and protein biomarkers testing via ultra-sensitive nucleases escalationTao Hu, Xinxin Ke, Yingying Yu, et al.
Environmental Science & Technology|July 9, 2026
From Screening-Level Profiling of Novel Brominated Flame Retardants to a Putative AOP-Informed Framework for DBDPE-Induced Cognitive Impairment in ZebrafishKaiwen Hu, Chenxin Gong, Conghui Shan, et al.
Pageof 25

Showing results (201-210 of 243) with videos related to

Sort By:
Pageof 25
Frontiers in Immunology|June 17, 2022
Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational TherapyShida Pan, Yingying Yu, Siyu Wang, et al.
Drugs in R&D|September 4, 2024
Pharmacokinetics, Mass Balance, and Biotransformation of [<sup>14</sup>C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy SubjectsShumao Ni, Sheng Ma, Yingying Yu, et al.
Cell Discovery|October 17, 2023
Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosisZhaoxian Cai, Xiaotian Wu, Zijun Song, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2021
Temporarily Epigenetic Repression in Bergmann Glia Regulates the Migration of Granule CellsShaoxuan Chen, Kunkun Zhang, Boxin Zhang, et al.
Frontiers in Immunology|April 23, 2026
Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemiaJianing Wang, Shida Pan, Chuyue Xiong, et al.
Frontiers in Immunology|May 13, 2026
Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemiaJianing Wang, Shida Pan, Chuyue Xiong, et al.
Plant Physiology and Biochemistry : PPB|April 16, 2025
Mechanisms of biocontrol of gray mold in postharvest pear fruits using the termite symbiont Streptomyces griseus H3950Daojing Yong, Yingying Yu, Shuai Zhao, et al.
Annals of Palliative Medicine|May 12, 2021
Clinical efficacy evaluation and prevention of adverse reactions in a randomized trial of a combination of three drugs in the treatment of cancerous pudendal neuralgiaJunjie Hou, Yifan Lin, Yanqiu Fang, et al.
Nature Communications|February 3, 2025
NAPTUNE: nucleic acids and protein biomarkers testing via ultra-sensitive nucleases escalationTao Hu, Xinxin Ke, Yingying Yu, et al.
Environmental Science & Technology|July 9, 2026
From Screening-Level Profiling of Novel Brominated Flame Retardants to a Putative AOP-Informed Framework for DBDPE-Induced Cognitive Impairment in ZebrafishKaiwen Hu, Chenxin Gong, Conghui Shan, et al.
Pageof 25